Evidence map›Paper›PMID 26469214›Full record

ArticleJournal of child and adolescent psychopharmacology2015

Evaluation of the Safety of Quetiapine in Treating Delirium in Critically Ill Children: A Retrospective Review.

Christine Joyce, Robert Witcher, Elizabeth Herrup, Savneet Kaur, Elena Mendez-Rico, Gabrielle Silver, Bruce M Greenwald, Chani Traube

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of child and adolescent psychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03572257 (Prospective, Double-Blind, Randomized Controlled Trial of Quetiapine as a Treatment for Delirium in Critically Ill Children), which is not on this map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03572257 phase2 / phase3withdrawnnot on this mapstarted 2019, after this paper: background citation

Prospective, Double-Blind, Randomized Controlled Trial of Quetiapine as a Treatment for Delirium in Critically Ill Children

TypeinterventionalSponsorMedical College of WisconsinRan2019 to 2020Enrolled0ConditionsDeliriumArmsQuetiapine, Placebo
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Quetiapine and Paediatric Psychiatrica:Psychopharmacology bulletin · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Delirium in the NICU.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  12. Article
  13. Review
  14. Effects of a Multidisciplinary Stewardship Program on the Prevention of Delirium in the Pediatric Intensive Care Unit.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Chlorpromazine as Treatment for Refractory Agitation Associated with Pediatric Delirium.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Christine Joyce1 Department of Pediatrics, NewYork-Presbyterian Hospital , New York, New York.
Robert Witcher2 Department of Pharmacy, NewYork-Presbyterian Hospital , New York, New York.
Elizabeth Herrup1 Department of Pediatrics, NewYork-Presbyterian Hospital , New York, New York.
Savneet Kaur3 Department of Pediatrics, Weill Cornell Medical College , New York, New York.
Elena Mendez-Rico2 Department of Pharmacy, NewYork-Presbyterian Hospital , New York, New York.
Gabrielle Silver4 Department of Psychiatry, Weill Cornell Medical College , New York, New York.
Bruce M Greenwald3 Department of Pediatrics, Weill Cornell Medical College , New York, New York.
Chani Traube3 Department of Pediatrics, Weill Cornell Medical College , New York, New York.
Cornell University · USNew York Hospital Queens · USNewYork–Presbyterian Hospital · US

Funding

Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
NCATS NIH HHS UL1 TR000457
6 · The paper itself

Abstract

objectiveQuetiapine is an atypical antipsychotic that has been used off-label for the treatment of intensive care unit (ICU) delirium in the adult population, with studies demonstrating both efficacy and a favorable safety profile. Although there is a potential role for quetiapine in the treatment of pediatric ICU delirium, there has been no systematic reporting to date of safety in this patient population.

methodsPharmacy records were used to identify 55 consecutive pediatric ICU patients who were diagnosed with delirium and received quetiapine. A comprehensive retrospective medical chart review was performed to collect data on demographics, dosing, and side effects.

resultsFifty patients treated between January 2013 and November 2014 were included, and five patients were excluded from the study. Subjects ranged in age from 2 months to 20 years. Median daily dose was 1.3 mg/kg/day, and median duration of treatment was 12 days. There were three episodes of QTc prolongation that were clinically nonsignificant with no associated dysrhythmia: Two resolved over time without intervention, and one resolved with decrease in quetiapine dosage. There were no episodes of extrapyramidal symptoms or neuroleptic malignant syndrome.

conclusionsIn this population of critically ill youth, short-term use of quetiapine as treatment for delirium appears to be safe, without serious adverse events. Further research is required to assess efficacy and evaluate for long-term effects. A prospective, randomized, placebo-controlled study of quetiapine in managing pediatric delirium is necessary.

Indexed as

AdolescentAntipsychotic AgentsChildChild, PreschoolCritical IllnessDeliriumFemaleHumansInfantMaleQuetiapine FumarateRetrospective StudiesYoung AdultAntipsychotic AgentsQuetiapine Fumarate

Identifiers

PMID26469214
PMCPMC4808274
OpenAlexW2153124585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.